Navigation Links
PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S
Date:7/8/2010

PALO ALTO, Calif., July 8 /PRNewswire/ -- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting precision, integrated suction for enhanced visibility, and a telescoping shaft that extends from 5.5 cm to 15 cm for improved surgical access. The PlasmaBlade 3.0S is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States.

"I have found the PlasmaBlade 3.0S to be an excellent precision dissection instrument for my spine surgery procedures," said John Peloza, M.D., director of the Center for Spine Care in Dallas, Texas. "The PlasmaBlade 3.0S not only precisely cuts and cauterizes pathological tissue but the reduced thermal damage to surrounding healthy tissue has translated into clinical benefits for my patients."

"The access and visibility with the PlasmaBlade 3.0S is excellent," said Helson Pacheco-Serrant, M.D., director of Neurosurgical Specialists of El Paso in El Paso, Texas. "The speed with which I can perform precise dissections near sensitive structures without worrying about thermal spread is a real advantage to both me and my patients. To date, my patients have experienced excellent post-operative recoveries, which I believe is due to the reduced thermal injury profile of this device."

PRECISE Study Results

PEAK Surgical has initiated a series of clinical studies, called the PRECISE Studies (Pulsed Plasma Radiofrequency Energy to ReduCe Thermal Injury and Improve Surgical HEaling), to examine the use of the PlasmaBlade in orthopedic, plastic and reconstructive, ENT and oncologic surgery. Initial study results have been presented at various medical congresses, including American College of Surgeons (ACS) and American Society of Breast Surgeons (ASBS) and additional results are expected later this year. These study results have demonstrated that the PlasmaBlade was associated with significant improvements in the following endpoints as compared with the standard of care:

  • 75 percent reduction in thermal injury depth (p=0.001)
  • 31 percent reduction in inflammation (p = 0.06)
  • 49 percent reduction in post-operative narcotic consumption (p=0.02)
  • 65 and 42 percent stronger healed incision strength at 3 and 6 weeks, respectively (p < 0.001)

"The clinical and economic benefits of the PlasmaBlade are making a positive impact on the healthcare community," said John Tighe, president and chief executive officer of PEAK Surgical. "We continue to see significant adoption of the PlasmaBlade by surgeons and hospitals as more than 25,000 surgical procedures have been performed with the PlasmaBlade to date since its launch in July 2008."

About PEAK Surgical, Inc.

PEAK Surgical, Inc. is a medical device company that has developed the PEAK PlasmaBlade®, a new tissue dissection device based on a proprietary technology that represents an important advance in radiofrequency surgical technologies. The PlasmaBlades are a family of disposable cutting devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral damage. These surgical devices come together with the PULSAR® Generator, which supplies pulsed plasma radiofrequency energy to the PlasmaBlades, to form the PEAK® Surgery System. The PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures in the United States, and for use in general surgery in the EU. In the United States, the PEAK Surgery System was launched in July 2008 and has been used by U.S. surgeons on more than 25,000 patients. For more information, please visit www.peaksurgical.com.


'/>"/>
SOURCE PEAK Surgical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities
2. Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players
3. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
4. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
5. Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
6. Simulated Surgical Systems, LLC Partners to Bring Simulation Advances to Surgical Training
7. KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
8. Ethicon Endo-Surgery Introduces Two New Staplers for Open Surgical Procedures at ASCRS
9. Ethicon Endo-Surgery Introduces HARMONIC FOCUS(R) Long Curved Shears for Deep Surgical Access
10. MitraClip Safely Relieves Symptoms in Patients With No Surgical Options
11. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... , Aug. 10, 2017  Physical Rehabilitation Network (PRN), ... in Lakewood, Colorado . The reputable clinic ... Lipkin , PT, DPT with his staff of four clinicians. ... of Pittsburgh and brings over 10 years of experience with ... Belmar PT marks the 10th PRN clinic in and ...
(Date:8/7/2017)... GAITHERSBURG, Md. , Aug. 7, 2017 /PRNewswire/ ... for healthcare member acquisition, retention, and engagement, announced ... Director of Strategy and Product Development, effective as ... strategic consulting and technology implementation strategy for our ... years of experience in consulting and business analytics ...
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... August 18, 2017 — Mediaplanet ... for active, healthy lifestyles and highlighting the importance of proactive eye and ear ... and shares the latest innovations in hearing aid technology. , According to ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a ... charity drive to generate community support for efforts to educate the local population on ... for all types of cancer. , Each day in America, roughly 4,600 new ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning firm that serves residential and commercial clients in the greater Houston region, ... raise community support for the fight against cancer. , Founded by Tony and ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
Breaking Medicine News(10 mins):